Literature DB >> 4086702

The use of new broad spectrum antibiotics.

F Follath.   

Abstract

Mesh:

Substances:

Year:  1985        PMID: 4086702     DOI: 10.1007/BF00273535

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  11 in total

1.  The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.

Authors:  R D Moore; C R Smith; P S Lietman
Journal:  J Infect Dis       Date:  1984-03       Impact factor: 5.226

2.  Evaluation of antibiotic usage: a comprehensive look at alternative approaches.

Authors:  C M Kunin
Journal:  Rev Infect Dis       Date:  1981 Jul-Aug

Review 3.  Current mechanisms of resistance to antimicrobial agents in microorganisms causing infection in the patient at risk for infection.

Authors:  H C Neu
Journal:  Am J Med       Date:  1984-05-15       Impact factor: 4.965

4.  Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.

Authors:  C C Sanders; W E Sanders; R V Goering; V Werner
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

5.  The role of the new penicillins and cephalosporins in the management of infection in granulocytopenic patients.

Authors:  J Klastersky
Journal:  Schweiz Med Wochenschr Suppl       Date:  1983

6.  Randomised, controlled trial of the comparative efficacy, auditory toxicity, and nephrotoxicity of tobramycin and netilmicin.

Authors:  A M Lerner; M P Reyes; L A Cone; D C Blair; W Jansen; G E Wright; R R Lorber
Journal:  Lancet       Date:  1983-05-21       Impact factor: 79.321

7.  A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients.

Authors:  V Fainstein; G P Bodey; L Elting; R Bolivar; M J Keating; K B McCredie; M Valdivieso
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

8.  Cefotaxime versus ampicillin, methicillin and netilmicin in combination for treatment of febrile episodes in patients with haematologic malignancy.

Authors:  H Friis; S Hoffmann; M Hansen; M M Hansen; T Justesen; N I Nissen
Journal:  Acta Med Scand       Date:  1983

9.  In vitro and in vivo antibacterial effects of combinations of beta-lactam antibiotics.

Authors:  N A Kuck; R T Testa; M Forbes
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

Review 10.  Serum level monitoring of antibacterial drugs. A review.

Authors:  M Wenk; S Vozeh; F Follath
Journal:  Clin Pharmacokinet       Date:  1984 Nov-Dec       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.